CardioRisk+
AI-Powered Cardiovascular Risk Assessment - Beyond Standard Models
Predict cardiovascular risk earlier and more accurately with AI-driven genetic and clinical insights
80% of Heart Attacks Are Preventable*
By identifying high-risk individuals early through genetic and clinical risk assessment, we can enable proactive prevention strategies.
What is CardioRisk+?
CardioRisk+ is a comprehensive, AI-powered cardiovascular risk assessment tool that goes beyond traditional models to provide earlier, more accurate risk detection.
What It Covers:
- Heart attack risk
- Diabetes
- Hypertension
- High cholesterol
- Obesity
- Atrial Fibrillation (AF)
- Chronic Kidney Disease (CKD)
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD, formerly NAFLD)
- Venous Thromboembolism (VTE)
Key Advantages of CardioRisk+
AI-powered insights
combining polygenic risk scores (PRS) with clinical data
More accurate risk prediction
than traditional methods
Seamless integration
into EMRs for real-time interactive decision support
Actionable insights
for personalized prevention and treatment
What Do Clinicians Say?
What Do Clinicians Say?
“By partnering with OpenDNA, we can now offer genetic screening that empowers our patients to take proactive steps towards managing their health and preventing future illness. Understanding individual risk profiles enables our physicians to provide more targeted and effective preventive care recommendations.”
Dr William Harper, CEO and Founder, Harper Health